CVD Prevention in clinical practice (European Guidelines on)
ESC Clinical Practice Guidelines
Cardiovascular Disease Prevention - Risk Assessment and Management
Professor Bax talks about the ESC Guidelines
The 2012 European Guidelines on CVD Prevention in Clinical Practice is a new shorter and more practical format around the 5 key questions of prevention: what is it, why is it needed, for whom and by whom and how can be provided?
Current versions available to download
Current translated versions available to download:
Joep Perk (Chairperson) (Sweden), Guy De Backer (Belgium), Helmut Gohlke (Germany), Ian Graham (Ireland), Zeljko Reiner (Croatia), Monique Verschuren (The Netherlands), Christian Albus (Germany),Pascale Benlian (France), Gudrun Boysen (Denmark), Renata Cifkova5 (Czech Republic), Christi Deaton (UK), Shah Ebrahim (UK), Miles Fisher (UK),Giuseppe Germano (Italy), Richard Hobbs(UK), Arno Hoes (The Netherlands),Sehnaz Karadeniz (Turkey), Alessandro Mezzani (Italy), Eva Prescott (Denmark),Lars Ryden (Sweden), Martin Scherer7 (Germany), Mikko Syvanne (Finland),Wilma J.M. Scholte Op Reimer (The Netherlands), Christiaan Vrints (Belgium),David Wood (UK), Jose Luis Zamorano (Spain), Faiez Zannad (France).
Declarations of Interest of the experts involved in the elaboration of the document.
Table of contents: Full Text (ESC Clinical Practice Guidelines)
What is cardiovascular disease prevention?
- Introduction, development of the Guidelines, evaluation methods, combining evaluation methods
What is prevention of cardiovascular disease needed?
- Scope of the problem, prevention of cardiovascular disease: a lifelong approach, prevention of cardiovascular desease pays off, ample room for improvement
Who should benefit from it?
- Strategies and risk estimation, genetics, age and gender, psychological risk factors, other biomarkers of risk, imaging methods in CVD prevention, other diseases with increase risk for CVD
How can CVD prevention be used?
- Principles of behavior change, smoking, nutrition, physical activity, management of psychological factors, body weight, blood pressure, treatment targets in patients with type 2 diabetes, lipids, antithrombotics, adherence
Where should programmes be offered?
- CVD in primary care: role of nurses, CVD in general practice, CVD in primary care: role of cardiologists, primary care-based self-help programmes, hopital-based programmes: hopital services, hospital-based programmes: specialized prevention centres, non-governemental organization programmes, action at the European level